Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges

  • Home
  • Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges

Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges

05, February 2022 |

Authors:

Tabassum T Rahman A Araf Y Ullah MA Hosen MJ

Abstract


Background: The coronavirus disease 2019 (COVID-19) has become a serious global health issue, especially for peo- ple with pre-existing health conditions. Patients dealing with asthma are presumed to be at higher risk as COVID-19 may cause severe respiratory distress. Main body: From the initial stage of the pandemic, several clinical trials and studies have assessed the association between COVID-19 and asthma; however, no significant association was reported. This may be due to the fact that most of the asthma cases remained undiagnosed and overlapping respiratory features make it difficult to differenti- ate between these two diseases. The pathomechanism of the conditions and the immune response generated in response to the conditions suggest that the presence of any of the conditions is very likely to influence the presence or severity of the other condition. So far, no specific treatments are known for COVID-19; however, the use of plasma therapy and broad-spectrum antiviral drugs during the initial phase of the pandemic and widespread vaccination during the latter phase has given positive outcomes in reducing COVID-19 cases as well as disease severity. Short conclusion: Taking asthma as an increased risk factor for COVID-19 morbidity, this article aims to provide com- prehensive insights into the risk and proper management of asthma patients during this COVID-19 pandemic. The common medications of asthma patients suppress their respiratory immune response that might facilitate cytokine storm in COVID-19 patients. Similarly, there are risks of viral-induced asthma exacerbations. Besides, different social issues such as shortage of medicines, SDOH, and delayed clinical trials put asthma patients through inconvenience. The primary focus at this point should be to reduce probable asthma attacks and severity to prevent hospitalization of asthma patients. Moreover, for better management of asthma patients maintaining an asthma action plan and healthy lifestyle, ensuring a nutritious diet, and developing self-management interventions can play a crucial role.